{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:20:34Z","timestamp":1769221234217,"version":"3.49.0"},"reference-count":30,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,1,24]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Hypocomplementaemic urticarial vasculitis syndrome (HUVS) is a rare immune complex-mediated disorder marked by non-pruritic urticarial lesions, hypocomplementaemia (low C1q levels), leucocytoclastic vasculitis and systemic manifestations (joint pain, angio-oedema and uveitis). Complications include renal disease, lung disease and acute laryngeal oedema that can prove fatal. Distinguishing HUVS from systemic lupus erythematosus (SLE) is challenging due to overlapping symptoms and diagnostic criteria. Here, we present the case of a male who presented with uveitis, maculopapular (and urticarial) rash and facial and joint swelling. Investigation revealed atypical antineutrophil cytoplasmic antibody, elevated antinuclear antibodies, low C1q and leucocytoclastic vasculitis on skin biopsy. Renal biopsy showed diffuse mesangial focal endocapillary proliferation with full-house immunofluorescence staining concerning for HUVS versus SLE class III nephritis. The management of HUVS is complicated by a lack of FDA-approved guidelines, with therapies ranging from non-steroidal anti-inflammatory drugs to immunosuppressants. The overlapping of HUVS, SLE and small lymphocytic lymphoma necessitates a collaborative multidisciplinary approach to control disease progression and improve outcomes.<\/jats:p>","DOI":"10.1136\/bcr-2024-262329","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:45:58Z","timestamp":1739277958000},"page":"e262329","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Rare presentation of hypocomplementaemic urticarial vasculitis syndrome (HUVS) overlapping with systemic erythematosus lupus (SLE) and small lymphocytic lymphoma (SLL)"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-6741","authenticated-orcid":false,"given":"Chen","family":"Chao","sequence":"first","affiliation":[{"name":"Rheumatology, Montefiore Medical Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Aksoy","sequence":"additional","affiliation":[{"name":"Internal Medicine, Roger Williams Medical Center, Providence, Rhode Island, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Varma","sequence":"additional","affiliation":[{"name":"Nephrology, Jacobi Medical Center, Bronx, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement E","family":"Tagoe","sequence":"additional","affiliation":[{"name":"Rheumatology, Montefiore Medical Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"2025082712135701000_18.2.e262329.1","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.waojou.2020.100107","article-title":"Management of urticarial vasculitis: A worldwide physician perspective","volume":"13","author":"Kolkhir","year":"2020","journal-title":"World Allergy Organ J"},{"key":"2025082712135701000_18.2.e262329.2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijwd.2021.01.021","article-title":"Urticarial vasculitis","volume":"7","author":"Gu","year":"2021","journal-title":"Int J Womens Dermatol"},{"key":"2025082712135701000_18.2.e262329.3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5114\/ada.2023.130474","article-title":"Hypocomplementemic urticarial vasculitis syndrome: a look beyond urticarial lesions","volume":"40","author":"Pereira","year":"2023","journal-title":"Postepy Dermatol Alergol"},{"key":"2025082712135701000_18.2.e262329.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07983.x"},{"key":"2025082712135701000_18.2.e262329.5","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:23:2:201"},{"key":"2025082712135701000_18.2.e262329.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02641.x"},{"key":"2025082712135701000_18.2.e262329.7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(24)00193-2","article-title":"Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis","volume":"38","author":"Davis","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"2025082712135701000_18.2.e262329.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.09.007"},{"key":"2025082712135701000_18.2.e262329.9","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.1.184"},{"key":"2025082712135701000_18.2.e262329.10","doi-asserted-by":"publisher","DOI":"10.1159\/000046312"},{"key":"2025082712135701000_18.2.e262329.11","first-page":"S41","article-title":"Hypocomplementemic urticarial vasculitis syndrome \u2013 a case report","volume":"46","author":"Vizjak","year":"2014","journal-title":"Pathology (Phila)"},{"key":"2025082712135701000_18.2.e262329.12","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1002\/ski2.205","article-title":"The lupus band test: A review of the sensitivity and specificity in the diagnosis of lupus erythematosus","volume":"3","author":"N\u00ed Maolcatha","year":"2023","journal-title":"Skin Health Dis"},{"key":"2025082712135701000_18.2.e262329.13","first-page":"36","article-title":"Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review","volume":"5","author":"Buck","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"2025082712135701000_18.2.e262329.14","first-page":"756","article-title":"Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge","volume":"106","author":"Grotz","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"2025082712135701000_18.2.e262329.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930"},{"key":"2025082712135701000_18.2.e262329.16","doi-asserted-by":"crossref","first-page":"11122046","DOI":"10.1046\/j.1365-2133.2000.03913.x","article-title":"Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis","volume":"143","author":"Worm","year":"2000","journal-title":"Br J Dermatol"},{"key":"2025082712135701000_18.2.e262329.17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2133.2000.03624.x","article-title":"Methotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reaction","volume":"143","author":"Borcea","year":"2000","journal-title":"Br J Dermatol"},{"key":"2025082712135701000_18.2.e262329.18","first-page":"36","article-title":"Methotrexate for urticarial vasculitis","volume":"72","author":"Stack","year":"1994","journal-title":"Ann Allergy"},{"key":"2025082712135701000_18.2.e262329.19","first-page":"231","article-title":"Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease","volume":"57","author":"Schwartz","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"2025082712135701000_18.2.e262329.20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.6.1278"},{"key":"2025082712135701000_18.2.e262329.21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.7.1753"},{"key":"2025082712135701000_18.2.e262329.22","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200001000-00005"},{"key":"2025082712135701000_18.2.e262329.23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2133.2008.08990.x","article-title":"Refractory urticarial vasculitis responsive to anti-B-cell therapy","volume":"160","author":"Mukhtyar","year":"2009","journal-title":"Br J Dermatol"},{"key":"2025082712135701000_18.2.e262329.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.04.008"},{"key":"2025082712135701000_18.2.e262329.25","doi-asserted-by":"publisher","DOI":"10.1080\/03009740600938647"},{"key":"2025082712135701000_18.2.e262329.26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4168\/aair.2012.4.4.245","article-title":"Plasmapheresis in a patient with 'refractory' urticarial vasculitis","volume":"4","author":"Kartal","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"key":"2025082712135701000_18.2.e262329.27","first-page":"286","article-title":"Successful treatment of normocomplementemic urticarial vasculitis with omalizumab: A report of three cases and literature review","volume":"38","author":"Rattananukrom","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2025082712135701000_18.2.e262329.28","doi-asserted-by":"crossref","unstructured":"Alharbi S , Sanchez-Guerrero J . Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab. Clin Med Insights Arthritis Musculoskelet Disord 2020;13. doi:10.1177\/1179544120967374","DOI":"10.1177\/1179544120967374"},{"key":"2025082712135701000_18.2.e262329.29","first-page":"854","article-title":"Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab","volume":"40","author":"Valor-M\u00e9ndez","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025082712135701000_18.2.e262329.30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/ajd.13995","article-title":"Treatment-resistant systemic lupus erythematosus-associated hypocomplementic urticarial vasculitis successfully treated with belimumab","volume":"64","author":"Pe\u00f1uelas Leal","year":"2023","journal-title":"Australas J Dermatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-262329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T19:14:03Z","timestamp":1756322043000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-262329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,11]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bcr-2024-262329"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-262329","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}